Gene therapy

In T1D, islets are the target for autoreactive T cell destruction. The absence of islets leads to insulin deficiencies and resultant hyperglycemia. Gene therapy is a useful technique to treat T1D as it can be applied from many different angles. The insulin gene can be replaced in a host or the autoreactive T cells suppressed.

    Related Conference of Gene therapy

    November 11-12, 2019

    Annual Congress on Diabetes, Metabolism and Obesity

    Sydney, Australia
    December 04-05, 2019

    3rd Annual Congress on Diabetes and Its Complications

    Tokyo, Japan
    December 9,10,2019

    International Congress and Expo on Diabetic Care

    Bangkok,Thailand
    December 12-13, 2019

    Annual Congress on Diabetes and Endocrinology

    Dubai, UAE
    January 27-28, 2020

    Global Summit On Diabetes & Endocrinology

    Bangkok, Thailand
    March 25-26, 2020

    29th World Diabetes & Heart Congress

    | Radisson Narita | Tokyo, Japan
    April 17-18, 2020

    3rd Global Meeting on Diabetes and Endocrinology

    Kualalumpur, Malaysia
    June 15-16, 2020

    29thEuropean Diabetes Congress

    | Barcelona, Spain
    August 17-18, 2020

    16th World Congress on Endocrinology & Diabetes

    | Copenhagen, Denmark
    Sept 22-23, 2020

    2nd Asia Pacific Endocrinology Congress

    | Singapore
    October 30-31, 2020

    Annual Summit on Metabolomics

    Vancouver, Canada
    November 16-17, 2020

    2nd Asia Pacific Diabetes and Endocrinology Congress

    Brisbane, Australia
    June 14-15, 2021

    diabetic 2021

    Abu Dhabi, UAE

    Gene therapy Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in